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Objective: The purposes of this study were to assess whether local anesthetics (LAs), such as ropivacaine
and bupivacaine, could induce apoptosis of rabbit annulus ﬁbrosus (AF) cells in vitro and further to
explore the possible underlying mechanism.
Methods: Rabbit AF cells at second passage were treated with saline solution and various concentrations
of LAs. Apoptosis of AF cells were examined by cell counting kit-8 (CCK-8), Annexin V assays, Hoechst
33342 staining, and Caspase-3, -9 activity assays. The expression of apoptosis-related markers was
detected by real-time PCR (RT-PCR) and Western Blot. The JC-1 staining was used to evaluate the change
of mitochondrial membrane potential (MMP). Moreover, the levels of reactive oxygen species (ROS) were
determined with ﬂuorescent probe DCFH-DA.
Results: The results of ﬂow cytometry indicated that LAs could induce apoptosis of rabbit AF cells in a
dose-dependent manner. Apoptosis was conﬁrmed by cell morphology, condensed nuclei and activation
of Caspase-3 and -9. In addition, the molecular data showed that LAs could signiﬁcantly up-regulate the
expression of Bax, accompanied by a signiﬁcant down-regulation of Bcl-2 expression. Furthermore, we
also observed that LAs resulted in alteration of MMP and accumulation of intracellular ROS in AF cells.
Blockade of ROS production by N-acetyl-L-cysteine (NAC) inhibited LAs-induced apoptosis.
Conclusions: These ﬁndings suggest that LAs in clinically relevant concentrations could induce apoptosis
of rabbit AF cells in vitro, and the mitochondrial pathway was, at least in part, involved in the LAs-
mediated apoptosis. Further investigations focusing on the potential cytotoxicity of LAs on IVD cells
are needed.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.L.-M. Xiong, Department of
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ternational. Published by Elsevier LIntroduction
In recent years, the therapeutic interventional techniques have
been commonly performed to improve the quality of life of patients
with low back pain1e4. Because of its advantages of minimal inva-
sion and simplicity, the utilization of interventional techniques as
a tool for diagnosing and treating spinal pain has sharply increased
in the medicare population5,6. Local anesthetics (LAs), such as
ropivacaine and bupivacaine, are widely used for interventional
spinal procedures and generally accepted as being safe. Recently,
several studies have focused on the potential toxic effects of bupi-
vacaine on intervertebral disc (IVD) cells7e10. Our previous study
also showed that LAs decrease the viability of rabbit IVD cells in atd. All rights reserved.
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mechanism of how LAs induce IVD cell death has not been fully
elucidated.
Prior evidence suggests that the mechanism by which LAs
induce cytotoxicity to IVD cells is predominantly related with cell
necrosis rather than cell apoptosis7,11. However, these studies
measuring toxicity to IVD cells were limited to the immediate or
short-term effects of LAs, and the long-term effects of LAs on IVD
cells have not been well explored. Interestingly, recent reports
concerning LAs toxicity on chondrocytes have suggested the in-
duction of apoptosis is increased signiﬁcantly at 120 h or 1 week
after withdrawal of LAs12e14, indicating that there exist different
mechanisms between the immediate or short-term effects and the
long-term effects involved in LAs-induced cytotoxicity. Because IVD
cells share a similar phenotype to cartilage chondrocytes, it is
reasonable and prudent to examine the long-term effects of LAs on
IVD cells and further test whether apoptosis is involved in LAs-
induced cytotoxicity.
Apoptosis plays essential roles in the elimination of unwanted,
damaged, or infected cells in multicellular organisms. Two main
apoptotic signaling pathways have been described: the intrinsic
and the extrinsic. The extrinsic pathway is activated by death re-
ceptors, leading to the formation of the death-inducing signal
complex. This event then results in activation of Caspase-8 to
cleavage of Caspase-3 and induction of cell apoptosis. The intrinsic
or mitochondrial pathway is activated by suppression of Bcl-2,
which gives rise to the permeabilization of the mitochondrial
membrane and subsequent the release of apoptotic signaling
molecules, for example, cytochrome c15. In the cytosol, cytochrome
c results in the formation of apoptosome containing cytochrome c,
apoptotic protease-activating factor (Apaf-1) and Caspase-9, which
then activates Caspase-3 and triggers subsequent apoptosis16.
In the current study, we ﬁrst investigated, using different
methods, whether LAs induce apoptosis of rabbit annulus ﬁbrosus
(AF) cells after withdrawal of LAs. In addition, we assessed the role
of mitochondrial pathway in the process of apoptosis induced by
LAs through detecting the apoptosis-related markers and the
mitochondrial function.
Methods
Isolation and culture of primary AF cells
All experiments in the present study were approved by the
Animal Care and Ethics Committee of Huazhong University of Sci-
ence and Technology and were in accordance with the guidelines
for the Care and Use of Laboratory Animals published by the US
National Institutes of Health.
Primary AF cell cultures were prepared from the surrounding
AF tissue of 3-month-old Japanese white rabbits as described
previously11,17. When the cells at the second passage reached an
80e90% conﬂuence, they were then seeded onto appropriate
culture plates for the following experiments. The cell densities
were 3.1  104 cells/cm2 for cell counting kit-8 (CCK-8), ﬂow
cytometry, ﬂuorescence microscope and real-time PCR (RT-PCR),
and 4  104 cells/cm2 for Western Blot and Caspases activity assay,
respectively. The cells were cultured for 24 h leading to adherence
prior to experimental treatment.
Treatment groups
We treated rabbit AF cells with the following concentrations of
LAs: 0.125%, 0.25% and 0.5% ropivacaine (Ropivacaine HCl; Astra-
Zeneca AB, Sweden); 0.125%, 0.25% and 0.5% bupivacaine (Bupiva-
caine HCl; Zhaohui Pharm, China). The concentrations used werethose of the commercial LAs solution, and their two-fold serially
diluted solutions with normal saline. Control groups were exposed
to sterile 0.9% saline under the same conditions. After 1-h exposure,
cells were immediately re-incubated in fresh culture medium to
allow time for recovery for 24 and 120 h.
Measurement of cell proliferation
Cell proliferation as well as the activity of mitochondrial de-
hydrogenases was measured by CCK-8 (Dojindo, Japan) as
described previously11,18. After exposure to LAs as described above,
100 mL Dulbecco's modiﬁed Eagle's medium/ham's F-12 (DMEM/F-
12; Gibco, Grand Island, NY, USA) containing 10 mL CCK-8 solutions
were added to each well of the plates. After incubation at 37C for
4 h, the absorbance at 450 nm was determined with a spectro-
photometer (BioTek, Winooski, VT, USA).
The impact of LAs on AF cell proliferation was also tested by the
5-ethynyl-2ʹ-deoxyuridine (EdU) incorporation assay. The assays
were performed as recommended by the manufacturer of EdU
detection kits (Ribobio, China). Fluorescent images were obtained
by a ﬂuorescence microscope (IX71, Olympus, Japan).
Detection of apoptosis by ﬂow cytometry
The AF cells from each treatment group were labeled using
Annexin V/propidium iodide (PI) (KeyGen Biotech, China) double
staining as described previously11,18. All samples were applied to
ﬂow cytometry (Becton Dickinson, Franklin Lakes, NJ, USA) using
CellQuest analysis software (BD, USA).
Identiﬁcation of apoptotic cells by morphology
To certiﬁcate the appearance of apoptosis, Hoechst 33342
staining (Beyotime, China) was carried out to observe the
condensed and fragmented nuclei. At designed time points, the
medium was removed and the cells were washed twice with
phosphate-buffered saline (PBS). The Hoechst 33342 dye at a con-
centration of 0.1 mg/mL was added to each well of the plates, and
the cells were incubated for 20 min in the dark. Morphologic
changes in apoptotic nuclei were observed and photographed using
a ﬂuorescence microscope with UV excitation at 350 nm. The
quantitative data were expressed as the percentage of apoptotic
nuclei relative to total number of nuclei counted.
Detection of Bax, Bcl-2, Caspase-3 and -9 mRNA by RT-PCR
Total RNA was extracted from AF cells of each sample using
Trizol reagent (Invitrogen, Carlsbad, CA, USA) and underwent
reverse transcription to cDNA with reverse transcriptase (ToYobo,
Japan). Speciﬁc primer pairs for Bax, Bcl-2 and Caspase-3 were
designed previously18. The sequences for b-actin and Caspase-9
were as follows: b-actin, forward: 5ʹ-CGAGATCGTGCGGGACAT-30
and reverse: 50-CAGGAAGGAGGGCTGGAAC-30, Caspase-9, forward:
50-GGAGGATTCCGTGATGTCTGT-30 and reverse: 50-CACGTTGTT-
GATGATGAGGC-30. Transcription levels of indicated genes and b-
actin were detected by RT-PCR on a SLAN Real-Time PCR System
(Shanghai Hongshi Medical Technology Co., China) with SYBR PCR
master mix (ToYobo, Japan). The relative amount for each gene
expression was calculated by the method of 2DDCT using b-actin
RNA as an internal control.
Western blot analysis
Total protein was extracted using a Western and IP Cell Lysis Kit
(Beyotime, China). To determine the release of cytochrome c from
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lated according to the manual of the Cell Mitochondria Isolation Kit
(Beyotime, China). The protein concentrations were determined by
using the BCA Protein Assay Kit (Beyotime, China). Equal amounts
of protein (30 mg) from each sample were loaded on 12% SDS-PAGE
gels and then transferred to PVDF membranes (Millipore, USA). The
membranes were blockedwith 5% nonfatmilk in TBST buffer for 2 h
at room temperature and incubated with primary antibodies
overnight at 4C. The following antibodies were used: anti-GAPDH
(1:1000; Tianjin Sungene Biotech Co, China), anti-Bcl-2 (1:1000,
Abgent), anti-Bax (1:1000, Abgent), anti-cytochrome c (1:1000,
Novus), anti-VDAC1 (1:200, Santa Cruz), anti-Caspase-3 (1:200,
Abcam), and anti-Caspase-9 (1:200; Boshide Biotechnology LLC,
China). After washing with TBST, membranes were incubated with
horseradish peroxidase conjugated secondary antibodies (Boshide
Biotechnology LLC, China) for 1 h at room temperature. The bands
were visualized by enhanced chemiluminescence kit (Thermo,
USA) according to the manufacturer's instructions.
Caspase-3 and -9 activity assay
Activities of Caspase-3 and -9 in AF cells were determined by the
Caspase-3 and -9 Colorimetric Assay Kit (Beyotime, China) ac-
cording to the manufacturer's instructions. The selective substrates
for assays of Caspase-3 and -9 activities were acetyl-Asp-Glu-Val-
Asp p-nitroanilide (Ac-DEVD-pNA) and acetyl-Leu-Glu-His-Asp p-
nitroanilide (Ac-LEHD-pNA), respectively. Brieﬂy, treated cells were
lysed with cell lysates buffer (100 mL per 2  106 cells) and
centrifuged for 15 min at 16,000 g. The supernatants (10 mL) were
then incubated with 80 ml detection buffer and Ac-DEVD-pNA
(10 mL) or Ac-LEHD-pNA (10 mL) for 4 h at 37C, and the absorbance
of pNA at 405 nmwas measured with a spectrophotometer (BioTek,
USA). Relative activities of Caspase-3 and -9 were expressed as the
fold of enzyme activity of treated groups to saline control.
Evaluation of mitochondrial membrane potential (MMP)
MMP was estimated by ﬂow cytometry following 5,50,6,60-tet-
rachloro-1,10,3,30-tetraethylbenzimidazolycarbocyanine iodide (JC-
1) (Beyotime, China) staining. Brieﬂy, the harvested AF cells were
washed once with PBS and re-suspended in the mixture of 0.5 mL
culture medium and 0.5 mL JC-1 staining ﬂuid. Subsequently, the
cells were incubated in the dark at 37C for 20 min. After incuba-
tion, the cells were washed with cold staining buffer twice and re-
suspended in 0.5 mL staining buffer before FACS analysis. The
values of MMP from each sample were expressed as ratios of red
ﬂuorescence intensity over green ﬂuorescence intensity.
To observe of the change of MMP in situ, the cells after exposure
to LAs were stained with JC-1 staining ﬂuid as described above. The
aggregate JC-1 (red ﬂuorescence) and the monomeric JC-1 (green
ﬂuorescence) were monitored under a laser scan confocal micro-
scopy (Nikon A1, Japan).
Measurement of reactive oxygen species (ROS)
The intracellular ROS level was determined by staining cells
with 20, 70-dichloroﬂuorescin diacetate (DCFH-DA) (SigmaeAldrich,
St. Louis, MO, USA), which is oxidized rapidly to the highly ﬂuo-
rescent compound dichloroﬂuorescein (DCF) in the presence of
ROS. Following recovery for 1 h, AF cells were collected, washed
once with PBS, and loaded with 20 mMDCFH-DA in the dark at 37C
for 20min. After incubation, the cells werewashedwith DMEM/F12
three times, and the mean ﬂuorescence intensity was measured by
ﬂow cytometry. Intracellular ROS levels in AF cells were also
observed in situ using ﬂuorescent probes DCFH-DA.Statistical analysis
One animal was used to perform each independent experiment;
cells from different animals were not pooled in any experiment.
Every independent experiment was performed in triplicate tech-
nical replicates. Results are presented as mean values with 95%
conﬁdence intervals (95% CI) from three independent experiments.
Statistical analysis was performed using SPSS for Windows soft-
ware (version 22; IBM Corp, NY, USA). Differences of means were
determined by one-way analysis of variance (ANOVA) with the
Bonferroni post hoc test. The homogeneity of variance of data was
veriﬁed using Levene's test before statistical analysis. The Dunnett's
T3 post hoc test was used when the conditions for data properties
were not fulﬁlled. A value of P < 0.05 was considered statistically
signiﬁcant.Results
Inhibitory effects of LAs on AF cell growth
To investigate the toxic effect of LAs on the growth of AF cells,
CCK-8 assay was used to evaluate cell proliferation by measuring
cellular dehydrogenases activities in general. Twenty-four and
120 h after 1-h exposure to LAs, the viability of AF cells were
signiﬁcantly inhibited by bupivacaine in a dose-dependent
manner, except 0.125% bupivacaine at 24 h [Fig. 1(A)]. Ropiva-
caine at a concentration of 0.5% also signiﬁcantly decreased the
viability of AF cells in comparison with saline control, although
lower doses of ropivacaine (0.125% and 0.25%) only caused a
detectable, but not signiﬁcant, decrease in viability at 24 or
120 h. To conﬁrm the inhibitory effects of LAs, we used the EdU
incorporation assay, a more sensitive and speciﬁc method, to
evaluate cell proliferation 120 h after LAs treatment. Similarly,
treatment with 0.5% ropivacaine, 0.25% and 0.5% bupivacaine
resulted in a signiﬁcant reduction in the number of EdU-positive
cells compared with the saline group [Fig. 1(B) and (C)]. These
data implied that LAs may have a long-term cytotoxic effect on
AF cells.Effects of LAs on apoptosis of AF cells
To assess whether LAs-mediated growth inhibition was related
to the induction of apoptosis, AF cells were stainedwith Annexin V-
FITC and PI for ﬂow cytometric analysis. Annexin V-positive and PI-
negative staining cells represent apoptotic cells. As shown in
Fig. 2(A), the increase in cell death of AF cells at 24 h after exposure
was more related with cell necrosis rather than cell apoptosis.
However, ﬂow cytometry on AF cells at 120 h following 1-h expo-
sure to LAs indicated that the decrease in viability at all of the
concentrations of LAs used was predominately due to apoptosis
[Fig. 2(B)]. There was a dose-dependent increase in the apoptotic
rate of rabbit AF cells 120 h after LAs treatment, although 0.125%
ropivacaine could not induce signiﬁcant cell apoptosis when
compared with the saline control [Fig. 2(C)].
To further conﬁrm the induction of apoptosis by LAs, the
apoptotic morphological changes were observed under a phase-
contrast microscopy or a ﬂuorescence microscope. The morpho-
logic features of AF cells after exposure to 0.5% ropivacaine and 0.5%
bupivacaine showed apoptotic morphology, including cell round-
ing, cell shrinkage, and almost detachment from the plates
[Fig. 3(A)]. In addition, Hoechst 33342 nuclear staining showed the
number of apoptotic nuclei containing condensed and fragmented
chromatin was increased signiﬁcantly after exposure to 0.5% ropi-
vacaine and 0.5% bupivacaine [Fig. 3(B) and (C)].
Fig. 1. Effects of ropivacaine and bupivacaine on the proliferation of AF cells. (A) Proliferation of AF cells was assessed by CCK-8 assay at 24 and 120 h after exposure to saline
solution, 0.125%, 0.25% and 0.5% ropivacaine (R), and 0.125%, 0.25% and 0.5% bupivacaine (B). 24 h, P ¼ 1.000 Saline vs R 0.125; P ¼ 0.061 Saline vs R 0.25; P ¼ 0.001 Saline vs R 0.5;
P ¼ 0.880 Saline vs B 0.125. 120 h, P ¼ 1.000 Saline vs R 0.125; P ¼ 0.122 Saline vs R 0.25; P ¼ 0.045 Saline vs B 0.125. The others P values <0.001. (B) Representative ﬂuorescent
images of the EdU incorporation assay (Magniﬁcation 100, scale bars ¼ 100 mm). (C) Quantitative analysis of EdU-positive cells. P ¼ 1.000 Saline vs R 0.125; P ¼ 0.106 Saline vs R
0.25; P ¼ 0.109 Saline vs B 0.125; P ¼ 0.001 Saline vs B 0.25. The others P values <0.001. Data are expressed as means with 95% CI from three independent experiments (*P < 0.05 vs
saline control; one-way ANOVA/Bonferroni).
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Fig. 2. Determinations of the numbers of necrotic, apoptotic, and viable cells of AF cells at 24 and 120 h following 1-h exposure to LAs. Representative graphs obtained by ﬂow
cytometry analysis after double staining with Annexin V-FITC and PI. (A): 24 h; (B): 120 h. In all four plots, the left lower quadrant shows live cells, the left upper and right upper
quadrants show necrotic cells, and the right lower quadrant shows apoptotic cells. (C) Histogram for statistical analysis shows the apoptosis rate of AF cells at 120 h after exposure to
LAs. The values are expressed as means with 95% CI from three independent experiments (*P < 0.05 vs saline control; one-way ANOVA/Bonferroni). P ¼ 0.658 Saline vs R 0.125;
P ¼ 0.005 Saline vs R 0.25; P ¼ 0.017 Saline vs B 0.125. The others P values <0.001. R: ropivacaine; B: bupivacaine.
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Fig. 3. Morphologic changes in apoptotic rabbit AF cells. (A) Phase-contrast photomicrograph of rabbit AF cells at 120 h after exposure to saline solution, 0.5% ropivacaine (R), and
0.5% bupivacaine (B). Apoptotic cells were characterized by cell shrinkage and detachment from the plates (Magniﬁcation 100, scale bars ¼ 100 mm). (B) Hoechst 33342 staining of
AF cells. Apoptotic nuclei showed condensed or fragmented DNA, and brightly stained with Hoechst 33342 (Magniﬁcation 200, scale bars ¼ 50 mm). (C) Histograms showing ratio
of condensed nuclei to total nuclei. The values are expressed as means with 95% CI from three independent experiments (*P < 0.05 vs saline control; one-way ANOVA/Bonferroni).
P ¼ 0.010 Saline vs R 0.5; P < 0.001 Saline vs B 0.5.
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of Bcl-2, cytochrome c release, the activation of Caspase-3, -9 and
Bax
To assess the potential role of mitochondrial pathway in LAs-
induced apoptosis, we detected the expression of apoptosis-
related genes by RT-PCR and Western blot. As shown in
Fig. 4(A), treatment with LAs up-regulated Bax, Caspase-3 and -9
mRNA levels in a dose-dependent manner, which was accom-
panied by suppression of Bcl-2 expression. Western blot also
revealed the expression level of Bax protein was increased and
that of Bcl-2 protein was decreased in response to LAs treatment
[Fig. 4(B)]. Caspase-9 is an initiator caspase in the mitochondrial
apoptosis pathway, and Caspase-3 is the down-stream effector
caspase. To further examine whether the LAs-induced release of
cytochrome c resulted in activation of cleaved Caspase-3 and -9,
Western blotting was performed on cells lysates. As shown in
Fig. 4(B), LAs enhanced the release of cytochrome c from mito-
chondria and generation of activated fragments of the Caspase-3
and -9 when compared to saline control. For further quantiﬁ-
cation of the activation of Caspase-3 and -9, we also measured
enzymatic activity of Caspase-3 and -9 by an in vitro colorimetric
assay. As shown in Fig. 4(C) and (D), LAs increased the activity ofboth Caspase-3 and -9 in AF cells in a dose-dependent manner.
Collectively, these data suggest that mitochondrial pathway was
likely to be involved in the apoptotic process.
LAs-induced depolarization of the MMP in AF cells
The collapse of MMP is considered as a key step of the apoptotic
pathway. To further illustrate whether LAs-mediated cell apoptosis
occurs through depolarization of MMP, we measured MMP in AF
cells with ﬂow cytometry analysis and in situ JC-1 staining.
Carbonyl cyanide 3-chlorophenylhydrazone (CCCP), which dissi-
pates the MMP, served as a positive control. The loss of the MMP
was reﬂected by a decrease in the ratio of red (JC-1 aggregates) to
green (JC-1 monomers). Compared with the saline control, ropi-
vacaine and bupivacaine decreased the ratio of red to green from
7.30 to 3.52 and 1.55, respectively [Fig. 5(A) and (B)]. As shown in
Fig. 5(C), AF cells after saline exposure exhibited primarily red
ﬂuorescence as JC-1 aggregates, indicating that the MMP was high.
In AF cells treated with 0.5% ropivacaine, some of the mitochondria
had lost their MMP, and the AF cells after exposure to 0.5% bupi-
vacaine showed more green ﬂuorescence as JC-1 monomers. These
ﬁndings indicate that LAs-induced apoptosis is associated with the
decline of MMP.
Fig. 4. The expression of apoptosis-related markers in rabbit AF cells at 120 h following exposure to LAs. (A) The mRNA levels of Bax, Bcl-2, Caspase-3 and -9 detected by RT-PCR.
Bax, P ¼ 1.000 Saline vs R 0.125. Bcl-2, P ¼ 1.000 Saline vs R 0.125; P ¼ 0.044 Saline vs R 0.25; P ¼ 0.172 Saline vs B 0.125. Caspase-3, P ¼ 1.000 Saline vs R 0.125. Caspase-9, P ¼ 1.000
Saline vs R 0.125; P ¼ 0.006 Saline vs R 0.25; P ¼ 1.000 Saline vs B 0.125. The others P values <0.001. (B) Representative Western blots for the expression of Bax, Bcl-2, cleaved
Caspase-3 and -9 and cytochrome c release. VDAC1: mitochondrial loading control. (C) Caspase-3 activity. P ¼ 1.000 Saline vs R 0.125; P ¼ 0.015 Saline vs R 0.25; P ¼ 0.025 Saline vs
B 0.125; P ¼ 0.002 Saline vs B 0.25. The others P values <0.001. (D) Caspase-9 activity. P ¼ 1.000 Saline vs R 0.125; P ¼ 0.028 Saline vs R 0.25; P ¼ 1.000 Saline vs B 0.125; P ¼ 0.001
Saline vs B 0.25. The others P values <0.001. The values are expressed as means with 95% CI from three independent experiments (*P < 0.05 vs saline control; one-way ANOVA/
Bonferroni). R: ropivacaine; B: bupivacaine.
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To determine whether the ROS generation is involved in LAs-
induced apoptosis, we investigated intracellular ROS level by
ﬂow cytometry after labeling cells with DCFH-DA. Rosup-induced
intracellular peroxide production was used as a positive control.
A dose-dependent increase of intracellular ROS level was
observed in AF cells at 1 h after exposure to different concen-
tration of LAs [Fig. 6(A) and (B)]. After treatment of AF cells with
0.5% ropivacaine and 0.5% bupivacaine, ROS reached a maximum
elevation of 1.74 or 2.39-fold greater than the saline control,
respectively. As shown in Fig. 6(C), the ﬂuorescence intensity of
ROS (green ﬂuorescence) was signiﬁcantly increased in the AF
cells treated with 0.5% ropivacaine and 0.5% bupivacaine in
comparison with saline control group.Inhibitory effects of N-acetyl-L-cysteine (NAC) on apoptotic events
induced by LAs
To investigate whether inhibition of ROS generation could pro-
tect against LAs-induced apoptosis, AF cells were pretreated with
5 mM NAC for 1 h before drug exposure. As shown in Fig. 7(A) and
(B), addition of NAC signiﬁcantly decreased LAs-induced ROS pro-
duction and ameliorated the loss of MMP induced by LAs (Table I).
In addition, pretreatment with NAC signiﬁcantly inhibited cell
apoptosis induced by LAs [Fig. 7(C)] and prevented the activation of
Caspase-3 and -9 [Fig. 7(D)]. Collectively, these results suggest that
ROS plays an important role in LAs-induced apoptotic pathway.
In order to demonstrate that the activation of Caspases is a key
step in the apoptotic pathway induced by LAs, AF cells were pre-
treated with z-VAD-fmk, a pan-caspase inhibitor, for 1 h before
Fig. 5. A decrease of MMP in AF cells at 120 h following exposure to LAs. (A) Representative dot plot by ﬂow cytometry analysis after labeling with ﬂuorescent probe JC-1. FL1-H:
green; FL2-H: red. CCCP served as a positive control. (B) Quantitative analysis of the shift of mitochondrial red ﬂuorescence to green ﬂuorescence among groups. The ratio of red/
green ﬂuorescence intensity was calculated. The values are expressed as means with 95% CI from three independent experiments (*P < 0.05 vs saline control; one-way ANOVA/
Bonferroni). P ¼ 0.558 Saline vs R 0.125; P ¼ 0.001 Saline vs B 0.125. The others P values <0.001. (C) Typical ﬂuorescence photomicrograph of in situ JC-1 staining output by laser scan
confocal microscopy. The photographs of red and green ﬂuorescence were taken under a same ﬁeld and thenwere merged (Magniﬁcation 200, scale bars ¼ 20 mm). R: ropivacaine;
B: bupivacaine.
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cantly attenuated LAs-induced apoptosis.
Discussion
Because both disc cell senescence and cell loss have been
implicated in the development of IVD degeneration19, any addi-
tional effect on IVD cell viability may accelerate the degenerativeprocess. In particular, the avascular nature of IVD could potentially
prolong the residence of LAs in the disc. Therefore, it is important to
examine the toxicity effects of LAs on IVD cells and further un-
derstand the molecular mechanism of anesthetic toxicity on IVD
cells. The present study indicates that the commonly used LAs, such
as ropivacaine and bupivacaine, cause a decrease in cellular
viability of rabbit AF cells. It is noteworthy that bupivacaine is more
toxic to AF cells than ropivacaine when diluted to the same
Fig. 6. An increase of ROS level in AF cells at 1 h following exposure to LAs. (A) Representative dot plot by ﬂow cytometry analysis after labeling with ﬂuorescent probe DCFH-DA.
FL1-H: green. (B) Histogram for statistical analysis shows the ROS levels in AF cells. The values are expressed as means with 95% CI from three independent experiments (*P < 0.05 vs
saline control; one-way ANOVA/Dunnett's T3). P ¼ 0.912 Saline vs R 0.125; P ¼ 0.061 Saline vs R 0.25; P ¼ 0.046 Saline vs R 0.5; P ¼ 0.130 Saline vs B 0.125; P ¼ 0.033 Saline vs B 0.25;
P ¼ 0.012 Saline vs B 0.5. (C) Representative ﬂuorescence photomicrograph of in situ DCFH-DA staining output by laser scan confocal microscopy (Magniﬁcation 200, scale
bars ¼ 20 mm). R: ropivacaine; B: bupivacaine.
X.-Y. Cai et al. / Osteoarthritis and Cartilage 23 (2015) 1763e1775 1771concentrations, which is in accordance with our previous studies
on rabbit IVD cells11. More interesting, we, for the ﬁrst time, suggest
that ropivacaine and bupivacaine could induce apoptosis of AF cells
in vitro after the drugs have been withdrawn and the apoptosis
induction by LAs is correlated with changes in mitochondrial
pathway.The results of CCK-8 and apoptosis assays showed that the
statistical signiﬁcance was different at lower LAs concentrations,
such as 0.25% ropivacaine. This discrepancy among the assays
may be mainly contributed to the differences in the assay
mechanism. The results of CCK-8 assay correlated closely with
the number of living cells according to the amount of an orange
Fig. 7. Protection of antioxidants against LAs-induced apoptosis. AF cells were pretreated with or without NAC (5 mM) for 1 h before exposure to LAs. (A) The effect of NAC on the
production of ROS by DCFH staining. P ¼ 0.001 R0.5 vs R 0.5þNAC; P ¼ 0.013 B0.5 vs B 0.5 þ NAC. (B) The effect of NAC on MMP by ﬂow cytometry analysis. P ¼ 0.032 R0.5 vs R
0.5þNAC; P ¼ 0.005 B0.5 vs B 0.5þNAC. (C) The effect of NAC and z-VAD-fmk on LAs-induced cell apoptosis by ﬂow cytometry analysis. P ¼ 0.002 R0.5 vs R 0.5þNAC; P ¼ 0.002 R0.5
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Table I
Protection of antioxidants against LAs-induced apoptosis
N Saline R 0.5 R 0.5þNAC R 0.5þz-VAD-fmk B 0.5 B 0.5þNAC B 0.5þz-VAD-fmk
ROS level 3 1.00 (1.00e1.00) 1.72 (1.54e1.89) 1.00 (0.84e1.16) 2.91 (2.37e3.46) 1.27 (1.10e1.45)
MMP 3 9.90 (8.25e11.54) 2.61 (2.34e2.89) 4.19 (3.41e4.96) 0.72 (0.36e1.07) 1.79 (1.44e2.14)
Apoptosis rate 3 2.7 (0.6e6.0) 12.6 (10.1e15.1) 3.3 (1.5e5.0) 3.4 (0.0e6.7) 53.5 (42.5e64.5) 9.8 (5.2e14.4) 39.0 (34.6e43.5)
Values are presented as means ± 95% CI. R: ropivacaine; B: bupivacaine.
Fig. 8. Necrosis or apoptosis of AF cells following interaction of LAs with mitochondrion.
X.-Y. Cai et al. / Osteoarthritis and Cartilage 23 (2015) 1763e1775 1773colored product (formazan) generated by dehydrogenases.
However, Annexin V detects phosphatidylserine (PS) trans-
position on the outer plasma membrane which occurs early in
the apoptotic process and precedes nuclear condensation, loss of
membrane integrity, and cell shrinkage20. Therefore, there is only
a correlation between CCK-8 and Annexin V assays, but the re-
sults may differ.
Extensive studies have shown that LAs have toxic effects on
other cell types, and it seems that the mechanism of toxicity is
probably related to the inhibition of mitochondrial energy meta-
bolism21. Different effects can coexist, including (1) speciﬁc inhi-
bition of mitochondrial respiratory chain complex I; (2) oxidative
phosphorylation uncoupling; (3) speciﬁc inhibition of the enzy-
matic mitochondrial activity; (4) the decrease of adenosine
triphosphate (ATP) production; and (5) the collapse of the
MMP22e26. In agreement with these studies, the decreased absor-
bance in CCK-8 assay reﬂects the reduction of activities of mito-
chondrial dehydrogenases. Moreover, LAs could decrease the MMP
of rabbit AF cells in a dose-dependent manner. These observationsvs R 0.5þz-VAD-fmk; P < 0.001 B0.5 vs B 0.5þNAC or B 0.5þz-VAD-fmk. AF cells were pretr
activities of caspase-3 and -9. The saline control was set at one. Caspase-3, P ¼ 0.015 R 0.5 v
P < 0.001 B 0.5 vs B 0.5þNAC. The values are expressed as means with 95% CI from three ind
untreated cells; one-way ANOVA/Dunnett's T3 and Bonferroni).may indicate that mitochondria are one of the targets of LAs toxicity
in AF cells. In addition to their important role in energy meta-
bolism, mitochondria have recently been considered as central
players in the regulation of cell death27. Mitochondrial insults can
induce either apoptosis or necrosis, with less severe injuries lead-
ing to apoptosis28. Recently, growing evidence suggests that LAs
could induce cell death through apoptosis, including chromatin
condensation, plasmamembrane blebbing, caspases activation, and
the release of cytochrome c frommitochondria29e33. In the present
study, our data also suggest that the characteristic of AF cell death
at 120 h after 1-h exposure to LAs appears to be more related with
cell apoptosis, as shown by a signiﬁcant increase in Annexin V-
positive cells, condensed and fragmented nuclei, and the activity of
Caspase-3 and -9, which are crucial mediators in the process of
apoptosis.
The molecular mechanism involved in LAs toxicity to IVD cells
has not been well established. As mentioned above, our recently
published data and those of Lee et al. have suggested that necrosis
may be the main mechanism of IVD cell death after 1-h exposure toeated with or without z-VAD-fmk at 30 mM for 1 h. (D) The effect of NAC on enzymatic
s R 0.5þNAC; P < 0.001 B 0.5 vs B 0.5þNAC. Caspase-9, P ¼ 0.006 R 0.5 vs R 0.5þNAC;
ependent experiments (*P < 0.05, NAC-treated or z-VAD-fmk-treated vs corresponding
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decrease in viability at 120 h following 1-h exposure to LAs was
predominately due to apoptosis. At ﬁrst glance, it may be surprising
that the mechanism of cell death switches from necrosis to
apoptosis when recovered 120 h after exposure to LAs for 1 h.
Nevertheless, this phenomenon is not unusual, for instance, Perez-
Castro and colleagues showed the caspase activation in human
neuronal cells by bupivacaine occurred with a time delay34. LAs
interfere with the mitochondrial energy metabolism, leading to a
possibility that immediate or short-term exposure to LAs depletes
cellular ATP which is required for the execution of apoptosis35,36.
Furthermore, Grouselle et al. reported the LAs-induced change of
MMP is reversible and there is potential restoration of MMP after
withdrawal of the LAs37. The previous researches did not evaluate
the long-term effects of LAs on IVD cells, therefore the toxic effects
of ropivacaine and bupivacaine observed in this study could be
missed. Given that a subpopulation of IVD cells possesses a chon-
drocytic phenotype, our results are particularly in agreement with
recent evidence of the long-term effects of LAs on chondrocytes. For
example, the results of Karpie and others suggested that the
apoptosis rate was increased with the extension of time after
withdrawal of LAs12e14.
Intracellular ROS is mainly generated in mitochondria and, at
the same time, can directly impair the mitochondrial function
when its formation is enhanced27. It has been reported that an in-
crease in ROS and a consequent loss of MMP are the typical phe-
nomena during mitochondria-dependent apoptosis38. Indeed,
elevated intracellular levels of ROS can lead to the disruption of
MMP and the release of cytochrome c, which results in the for-
mation of apoptosome and then triggers caspases cascade39. In this
study, our results revealed a dose-dependent increase in the
amount of intracellular ROS, loss of theMMP, release of cytochrome
c and activation of both Caspase-3 and -9 in AF cells after treatment
with LAs. In addition to be affected by ROS, the MMP could also be
directly regulated by Bcl-2 family proteins, such as pro-apoptotic
protein Bax and anti-apoptotic protein Bcl-240. Furthermore, we
observed that the expression of pro-apoptotic Bax was markedly
increased, and that of anti-apoptotic Bcl-2 was concomitantly
declined in AF cells after exposure to LAs. Taken these results
together, it could be possibly concluded that the mitochondrial
pathway is involved in apoptotic process of AF cells in response to
treatment with LAs.
Our results were highly reproducible, but some limitations of
this study should be noted. First, our experiments were per-
formed in vitro, and the conclusions are not necessarily indicative
of what happens in vivo. Second, because of hardness to get
healthy human IVD tissue, we chose rabbit AF cells to examine
the toxicity of LAs in healthy cells. Although rabbit IVD cells have
been shown to respond to LAs similarly to human IVD cells7,
further investigation using healthy human IVD cells is warranted.
Third, our studies only correlate the activity of mitochondrial
dehydrogenases and the MMP. In future studies, we plan to
systematically investigate the effect of LAs on mitochondria, such
as mitochondrial permeability transition, changes in ATP pro-
duction and mitochondrial protein levels, and mitochondrial
DNA damage.
In conclusion, our data demonstrated that LAs, such as ropiva-
caine and bupivacaine, signiﬁcantly induced apoptosis in rabbit AF
cells in vitro after withdrawal of the LAs. LAs-induced apoptosis was
associated with activation of the intrinsic apoptosis pathway.
Coupled with our recently published data and those of Lee et al.7,11,
the possible mechanism involved in LAs-induced cell death on IVD
cells was summarized in Fig. 8. These ﬁndings may provide insight
into the underling mechanism of IVD cell death after exposure to
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